Juno Therapeutics (Germany)
Juno Therapeutics, Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Juno Therapeutics (Germany), Germany, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
55%
Total
Publications
51
Total Open
Publications
28
Total
Citations
2.2K
Open Access
Percentage
55%
Total
Publications
51
Total Open
Publications
28
Total
Citations
2.2K
Breakdown
Publisher Open
22%
Both
24%
Other Platform Open
4%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
10
Hybrid 28%
6
No Guarantees 24%
5
Other Platform Open
Domain 77%
10
Institution 69%
9
Public 8%
1
Other Internet 8%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 10 |
Technical University Munich - mediaTUM – the media and publications repository of the Technical University Munich | Institution | 3 |
DANS - Data Archiving and Networked Services | Institution | 2 |
Unknown Repository | Other Internet | 1 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
Universidad Autónoma de Madrid - Biblos-e Archivo | Institution | 1 |
São Paulo State University - UNESP Institutional Repository | Institution | 1 |
Max Planck Society - MPG.PuRe | Institution | 1 |
Ludwid Maxmilian's Universitat Munchen - Open access LMU | Institution | 1 |
Figshare | Public | 1 |